The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services.  Founded in 1949, we are relentless in pursuit of our mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

LLS has helped blood cancer victims in countless ways.  We invested more than $424 million in research, $51.3 million in 2005 alone.  We have made more than 2.5 million contacts with patients and families in the fiscal year 2005 through our Information Resource Center (IRC), Web site and community-based patient service program. 

For more information on all of the Society's programs, visit www.lls.org/in.

 
The North Star 2015 Vision

The North Star 2015 Vision describes a future which The Leukemia & Lymphoma Society's (LLS) volunteers and staff aspire to create.  It is a future in which the Society will have transformed the lives of people with blood cancer and the healthcare landscape of patients and their families and caregivers navigate.

We envision that in the year 2015 the great majority of people who have been diagnosed with a blood cancer will be cured, or they will manager their illness with good quality of life.  Society-led collaborations among nonprofit, commercial and governmental organizations will have created changes in healthcare delivery and enable patients to access the most effective treatments and care, from diagnosis through survivorship.  In 2015, patients, their families and caregivers will have the support they need to minimize physical and emotional suffering and to cope effectively throughout their cancer journeys.

To achieve this vision, LLS will increase the impact of its services and programs by always focusing on patient outcomes; create new avenues to advance its mission; build and sustain a strong culture and superior capabilities among staff and volunteers.  The Vision will guide LLS's strategic planning processes, so that the outcomes envisioned for blood cancer patients and their families and caregivers are realized by 2015.